Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins.

Braun E, Hotter D, Koepke L, Zech F, Groß R, Sparrer KMJ, Müller JA, Pfaller CK, Heusinger E, Wombacher R, Sutter K, Dittmer U, Winkler M, Simmons G, Jakobsen MR, Conzelmann KK, Pöhlmann S, Münch J, Fackler OT, Kirchhoff F, Sauter D.

Cell Rep. 2019 May 14;27(7):2092-2104.e10. doi: 10.1016/j.celrep.2019.04.063.

2.

Serologic Prevalence of Ebola Virus in Equatorial Africa.

Steffen I, Lu K, Yamamoto LK, Hoff NA, Mulembakani P, Wemakoy EO, Muyembe-Tamfum JJ, Ndembi N, Brennan CA, Hackett J Jr, Stramer SL, Switzer WM, Saragosti S, Mbensa GO, Laperche S, Rimoin AW, Simmons G.

Emerg Infect Dis. 2019 May;25(5):911-918. doi: 10.3201/eid2505.180115.

3.

Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus.

Jin J, Simmons G.

Viruses. 2019 Mar 28;11(4). pii: E305. doi: 10.3390/v11040305. Review.

4.

Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex.

Henss L, Yue C, Kandler J, Faddy HM, Simmons G, Panning M, Lewis-Ximenez LL, Baylis SA, Schnierle BS.

Viruses. 2019 Jan 18;11(1). pii: E82. doi: 10.3390/v11010082.

5.

Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo.

Hoff NA, Mukadi P, Doshi RH, Bramble MS, Lu K, Gadoth A, Sinai C, Spencer D, Nicholson BP, Williams R, Mossoko M, Ilunga-Kebela B, Wasiswa J, Okitolonda-Wemakoy E, Alfonso VH, Steffen I, Muyembe-Tamfum JJ, Simmons G, Rimoin AW.

J Infect Dis. 2019 Jan 29;219(4):517-525. doi: 10.1093/infdis/jiy499.

6.

Neutralizing Antibodies Inhibit Chikungunya Virus Budding at the Plasma Membrane.

Jin J, Galaz-Montoya JG, Sherman MB, Sun SY, Goldsmith CS, O'Toole ET, Ackerman L, Carlson LA, Weaver SC, Chiu W, Simmons G.

Cell Host Microbe. 2018 Sep 12;24(3):417-428.e5. doi: 10.1016/j.chom.2018.07.018. Epub 2018 Aug 23.

PMID:
30146390
7.

Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors.

Bramble MS, Hoff N, Gilchuk P, Mukadi P, Lu K, Doshi RH, Steffen I, Nicholson BP, Lipson A, Vashist N, Sinai C, Spencer D, Olinger G, Wemakoy EO, Illunga BK, Pettitt J, Logue J, Marchand J, Varughese J, Bennett RS, Jahrling P, Cavet G, Serafini T, Ollmann Saphire E, Vilain E, Muyembe-Tamfum JJ, Hensely LE, Simmons G, Crowe JE Jr, Rimoin AW.

J Infect Dis. 2018 Nov 5;218(12):1929-1936. doi: 10.1093/infdis/jiy453.

8.

An attenuated replication-competent chikungunya virus with a fluorescently tagged envelope.

Jin J, Sherman MB, Chafets D, Dinglasan N, Lu K, Lee TH, Carlson LA, Muench MO, Simmons G.

PLoS Negl Trop Dis. 2018 Jul 31;12(7):e0006693. doi: 10.1371/journal.pntd.0006693. eCollection 2018 Jul.

9.

Susceptibility of Chikungunya Virus to Inactivation by Heat and Commercially and World Health Organization-Recommended Biocides.

Franz S, Friesland M, Passos V, Todt D, Simmons G, Goffinet C, Steinmann E.

J Infect Dis. 2018 Sep 22;218(9):1507-1510. doi: 10.1093/infdis/jiy359.

10.

Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus Epidemics.

Simmons G, Stone M, Busch MP.

Clin Infect Dis. 2018 Apr 3;66(8):1181-1183. doi: 10.1093/cid/cix972. No abstract available.

11.

Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection.

Rimoin AW, Lu K, Bramble MS, Steffen I, Doshi RH, Hoff NA, Mukadi P, Nicholson BP, Alfonso VH, Olinger G, Sinai C, Yamamoto LK, Ramirez CM, Okitolonda Wemakoy E, Kebela Illunga B, Pettitt J, Logue J, Bennett RS, Jahrling P, Heymann DL, Piot P, Muyembe-Tamfum JJ, Hensley LE, Simmons G.

J Infect Dis. 2018 Jan 4;217(2):223-231. doi: 10.1093/infdis/jix584.

12.

Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.

Tsai WY, Youn HH, Brites C, Tsai JJ, Tyson J, Pedroso C, Drexler JF, Stone M, Simmons G, Busch MP, Lanteri M, Stramer SL, Balmaseda A, Harris E, Wang WK.

Clin Infect Dis. 2017 Nov 13;65(11):1829-1836. doi: 10.1093/cid/cix672.

13.

Correction: Correction: A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa.

Grard G, Fair JN, Lee D, Slikas E, Steffen I, Muyembe JJ, Sittler T, Veeraraghavan N, Ruby JG, Wang C, Makuwa M, Mulembakani P, Tesh RB, Mazet J, Rimoin AW, Taylor T, Schneider BS, Simmons G, Delwart E, Wolfe ND, Chiu CY, Leroy EM.

PLoS Pathog. 2017 Sep 7;13(9):e1006583. doi: 10.1371/journal.ppat.1006583. eCollection 2017 Sep.

14.

Higher Serum Alanine Transaminase Levels in Male Urokinase-Type Plasminogen Activator-Transgenic Mice Are Associated With Improved Engraftment of Hepatocytes but not Liver Sinusoidal Endothelial Cells.

Fomin ME, Beyer AI, Publicover J, Lu K, Bakkour S, Simmons G, Muench MO.

Cell Med. 2016 Nov 23;9(3):117-125. doi: 10.3727/215517916X693375. eCollection 2017.

15.

First cases of Zika virus-infected US blood donors outside states with areas of active transmission.

Williamson PC, Linnen JM, Kessler DA, Shaz BH, Kamel H, Vassallo RR, Winkelman V, Gao K, Ziermann R, Menezes J, Thomas S, Holmberg JA, Bakkour S, Stone M, Lu K, Simmons G, Busch MP.

Transfusion. 2017 Mar;57(3pt2):770-778. doi: 10.1111/trf.14041. Epub 2017 Feb 23.

PMID:
28229475
16.

Zika Virus Tissue and Blood Compartmentalization in Acute Infection of Rhesus Macaques.

Coffey LL, Pesavento PA, Keesler RI, Singapuri A, Watanabe J, Watanabe R, Yee J, Bliss-Moreau E, Cruzen C, Christe KL, Reader JR, von Morgenland W, Gibbons AM, Allen AM, Linnen J, Gao K, Delwart E, Simmons G, Stone M, Lanteri M, Bakkour S, Busch M, Morrison J, Van Rompay KK.

PLoS One. 2017 Jan 31;12(1):e0171148. doi: 10.1371/journal.pone.0171148. eCollection 2017.

17.

Duration of Dengue Viremia in Blood Donors and Relationships Between Donor Viremia, Infection Incidence and Clinical Case Reports During a Large Epidemic.

Busch MP, Sabino EC, Brambilla D, Lopes ME, Capuani L, Chowdhury D, McClure C, Linnen JM, Prince H, Simmons G, Lee TH, Kleinman S, Custer B; International Component of the NHLBI Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).

J Infect Dis. 2016 Jul 1;214(1):49-54. doi: 10.1093/infdis/jiw122. Epub 2016 Apr 1.

18.

Inhibitory Antibodies Targeting Emerging Viruses: Advancements and Mechanisms.

Jin J, Simmons G.

Clin Vaccine Immunol. 2016 Jul 5;23(7):535-9. doi: 10.1128/CVI.00136-16. Print 2016 Jul. Review.

19.

High Incidence of Chikungunya Virus and Frequency of Viremic Blood Donations during Epidemic, Puerto Rico, USA, 2014.

Simmons G, Brès V, Lu K, Liss NM, Brambilla DJ, Ryff KR, Bruhn R, Velez E, Ocampo D, Linnen JM, Latoni G, Petersen LR, Williamson PC, Busch MP.

Emerg Infect Dis. 2016 Jul;22(7):1221-8. doi: 10.3201/eid2207.160116. Epub 2016 Jul 15.

20.

Correction: A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa.

Grard G, Fair JN, Lee D, Slikas E, Steffen I, Muyembe JJ, Sittler T, Veeraraghavan N, Ruby JG, Wang C, Makuwa M, Mulembakani P, Tesh RB, Mazet J, Rimoin AW, Taylor T, Schneider BS, Simmons G, Delwart E, Wolfe ND, Chiu CY, Leroy EM.

PLoS Pathog. 2016 Mar 18;12(3):e1005503. doi: 10.1371/journal.ppat.1005503. eCollection 2016 Mar. No abstract available.

Supplemental Content

Loading ...
Support Center